<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80732">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02068547</url>
  </required_header>
  <id_info>
    <org_study_id>201308043</org_study_id>
    <nct_id>NCT02068547</nct_id>
  </id_info>
  <brief_title>Bone Marrow Aspirate Concentration in Posterior Cervical Fusion</brief_title>
  <acronym>BMAC</acronym>
  <official_title>Bone Marrow Aspirate Concentration in Posterior Cervical Fusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Harvest Technologies</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to test if that combining bone marrow aspirate (removing
      bone marrow with a needle) concentration with locally harvested (collected) autograft
      (patient's own bone from another part of the body) for use as the bone graft results in
      equal rates of a successful procedure (fusion), as compared to current best practice in
      high-risk patients undergoing posterior cervical fusion.

      Hypothesis: Bone marrow aspirate concentration combined with locally harvested autograft
      results in equivalent rates of bony fusion, as compared to current best practice in
      high-risk patients undergoing posterior cervical decompression and fusion.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Rate of Fusion</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Rate of fusion - (6, 12, and 24 months) Rate of fusion will be assessed by flexion extension X-rays at routine follow-up, translation method (&lt;2mm) and/or by computed tomography (CT) scan at 2 year post-operatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phyiscial and mental health from subject's point of view</measure>
    <time_frame>24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Short Form 36 (SF-36) is a profile of functional health and well-being scores as well as psychometrically-based physical and mental health summary measures and a preference-based health utility index.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neck pain affects every day activities</measure>
    <time_frame>24 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire that helps determine how a subject's neck pain affects their ability to manage every day activities.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cervical Myelopathy</condition>
  <condition>Radiculopathy</condition>
  <arm_group>
    <arm_group_label>Surigical Best Practice</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group 1 will receive current best practice for posterior instrumented fusion (locally harvested autograft, demineralized bone matrix, and cadaveric allograft)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group II, will receive locally harvested autograft and 20 cc of bone marrow aspirate concentration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>locally harvested autograft, demineralized bone matrix, and cadaveric allograft</intervention_name>
    <arm_group_label>Surigical Best Practice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bone Marrow Aspirate</intervention_name>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 75

          -  Have at least one of the following high risk qualifications: BMI &gt;30, Rheumatoid
             Arthritis, Osteoporosis, Current smoker

          -  Able to cooperate in the completion of standardized outcome measures (SF-36 &amp; NDI)

          -  Willing and able to comply with study protocol

          -  cervical spondylosis requiring posterior instrument fusion

        Exclusion Criteria:

          -  Pre-existent neurologic disorder or mental disorder that would preclude accurate
             evaluation (psychiatric disease, Parkinson's disease, Alzheimer's disease)

          -  History of previous anterior cervical fusion at the operative site

          -  Pregnant

          -  Active malignancy

          -  Previous history of posterior cervical decompression?
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilson Z Ray, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa A Beck</last_name>
    <phone>314-362-3114</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wilson Z Ray, MD</last_name>
      <phone>314-362-3577</phone>
    </contact>
    <contact_backup>
      <last_name>Melissa A Beck</last_name>
      <phone>314-362-3114</phone>
    </contact_backup>
    <investigator>
      <last_name>Wilson Z Ray, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University in St. Louis School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Beck</last_name>
      <phone>314-362-3114</phone>
      <email>beckm@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Wilson Z Ray, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 19, 2014</lastchanged_date>
  <firstreceived_date>February 17, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>posterior cervical fusion</keyword>
  <keyword>posterior cervical decompression</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bone Marrow Diseases</mesh_term>
    <mesh_term>Spinal Cord Diseases</mesh_term>
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
